MELINDA LACY: Open Payments
NPI 1982005146 · HARRISONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 9 payments from 7 companies in 2025. Trend: 2023 $1,348 · 2024 $1,262 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Organon LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: FANAPT, REXULTI, NEXPLANON, MOUNJARO, XIFAXAN, INGREZZA.
Industry payments across MO — which companies pay providers there.
